国际标准期刊号: 2475-7640

临床与实验移植杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Hematopoietic Somatic Cell Transplantation Application

Hui-Yua Tsai

Stem cell transplantation has been wont to cure thousands of individuals WHO have cancer; however there are unit serious risks to the current treatment. Before undergoing somatic cell transplantation, patients considering this treatment ought to discuss the risks and advantages with their doctors. The risks of somatic cell transplantation have attenuated with the passing of every decade. In progress analysis is probably going to still improve the procedure. For a few diseases and patients, however, effective new medication and new styles of therapies could also be higher treatment choices than somatic cell transplantation. Doctors and their patients can take into account several factors once deciding whether or not somatic cell transplantation is that the best treatment possibility.